Microlaryngoscopy. Other diseases of larynx
Conditions
Interventions
Intervention 1: Dexmedetomidine group: 30 patients who received 1 µg/kg of dexmedetomidine over 10 minutes before anesthesia induction followed by 0.05 mg/kg/h as infusion after anesthesia induction.
Sponsors
Magrabi Eye, ENT and Dental Center, Doha, Qatar
Eligibility
Sex/Gender
All
Age
18 Years to 65 Years
Inclusion criteria
Inclusion criteria: Age 18-65 years ASA grade I/III Scheduled for microlaryngoscopy
Exclusion criteria
Exclusion criteria: Patients with known allergy to study drugs Coronary artery disease Pulmonary disease Arrhythmia Pregnancy Renal impairment
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Hemodynamic stress response. Timepoint: Intraoperative. Method of measurement: Systolic Blood Pressure , Mean Arterial Pressure, Heart Rate were monitored. | — |
Secondary
| Measure | Time frame |
|---|---|
| Intraoperative requirement of propofol. Timepoint: Intraoperative. Method of measurement: Total dose guided by bispectral index.;Sedation. Timepoint: Postoperative. Method of measurement: Ramsay score.;Analgesia. Timepoint: Postoperative. Method of measurement: Visual Analogue Scale.;Anesthesia duration. Timepoint: Intraoperative. Method of measurement: Time measurement.;Recovery time. Timepoint: Postoperative. Method of measurement: Time measurement. | — |
Countries
Qatar
Contacts
Public ContactMOHAMED ORIBY
Faculty of Medicine, Tanta University
Outcome results
None listed